Pristiq (desvenlafaxine) Extended-Release Tablets 50 mg, 30 count bottle, Rx only, Distributed by Wyeth Pharmaceuticals, Inc., NDC 0008-1211-30
Published July 2, 2014 · Recall initiated: April 16, 2014
Summary
FDA records drug Class II recall D-1409-2014, published July 2, 2014 and initiated April 16, 2014. Recalling firm: Pfizer Us Pharmaceutical Group; Status: Terminated; Reported quantity: 220,761 bottles; Lot: H74477, H74478, Exp. 03/16, H74479, H79766 Exp. 05/16. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign Tablets/Capsules: Pfizer is recalling 50 mg Pristiq (desvenlafaxine) extended release tablets because a single Pristiq 100 mg tablet was found in a bottle of 50 mg Pristiq.
What to do
Voluntary: Firm initiated · Letter
Get an email if PRISTIQ has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- PRISTIQ
- Manufacturer
- Pfizer Us Pharmaceutical Group
- Distributor
- Nationwide
- UPC
- 0300081210306
- Lot
- H74477, H74478, Exp. 03/16, H74479, H79766 Exp. 05/16
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADextroamphetamine Sulfate Tablets, USP, 10 mg, 100-count bottles, Rx only, Barr Laboratories, Inc., Pomona, NYJuly 2, 2014
- FDAMuro 128 (sodium chloride) hypertonicity ophthalmic ointment, 5%, packaged in a) 1 g tube per carton,July 2, 2014
- FDAGemcitabine For Injection USP, 1 g, (lyophilized), For Intravenous Use Only, Sterile Single Use Vial, Rx only,July 2, 2014
- FDASodium Chloride Hypertonicity Ophthalmic Ointment, 5%, 1/8 oz. (3.5 g) tube per carton, Distributed by MajorJuly 2, 2014
- FDAGSF LLC Shelled Walnuts, Kernel Combo Halves & Pieces, 15% New Wt. 25 lbs. GSF LLC, Visalia, CA 93290July 2, 2014
- FDAAltrus Thermal Tissue Fusion Handpieces under the following specifications: 1) 10mm x 16 cm Catalog Number:June 25, 2014
Questions about this recall
Was Pristiq (desvenlafaxine) Extended-Release Tablets 50 mg, 30 count bottle, Rx only, Distributed by Wyeth Pharmaceuticals, Inc., NDC 0008-1211-30 recalled?
Yes. FDA published recall D-1409-2014 on July 2, 2014. Reported hazard: Presence of Foreign Tablets/Capsules: Pfizer is recalling 50 mg Pristiq (desvenlafaxine) extended release tablets because a single Pristiq 100 mg tablet was found in a bottle of 50 mg Pristiq.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: PRISTIQ. UPC: 0300081210306.